A Double-Blind Comparison of Meptazinol versus Distalgesic in Acute or Chronic Pain Presenting to the General Practitioner

Publisher Website
Google Scholar
Abstract
The results of treating acute or chronic pain with Distalgesic were compared in a double-blind fashion with the new partial antagonist analgesic meptazinol. Both drugs had similar analgesic time effect profiles and both were acceptable to doctor and patients. However the side-effect profile was better for meptazinol than Distalgesic and so meptazinol may be a useful alternative to Distalgesic in the treatment of everyday pain states.